CLO20-052: Hospitalization and Supportive Care Medication (SCM) Utilization Among Patients Treated With Talazoparib (TALA) Monotherapy: An Integrated Analysis of Five Clinical Trials (Phase 1-3) in Advanced Cancers

Authors :: Miguel Martin
Johann S. de Bono
Lida A. Mina
Hope S. Rugo
Ying Chen
Johannes Ettl
Zev A. Wainberg
Sara A. Hurvitz
Ruben G.W. Quek
Source :: Journal of the National Comprehensive Cancer Network. 18:CLO20-052
Publication Year :: 2020
Publisher :: Harborside Press, LLC, 2020.

Subjects :: Clinical trial
chemistry.chemical_compound
medicine.medical_specialty
Oncology
chemistry
business.industry
Internal medicine
medicine
Talazoparib
business
Phase (combat)

Tools